Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 167 of 1,261
  1. US 11771745

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  2. US 11773085

    Methods and compounds for treating disorders

    FOGHORN THERAPEUTICS INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  3. US 11771667

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  4. US 11773110

    Heterocycle amines and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  5. US 11771723

    Bifidobacterium longum NCIMB 41676

    PrecisionBiotics Group Limited · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  6. US 11773083

    Solid state forms of Belumosudil and Belumosudil salts

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  7. US 11771739

    Methods and compositions for treating microbial inflammation

    THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  8. US 11771752

    Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

    Prime Bio, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  9. US 11771743

    Methods for preventing or treating allergy by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  10. US 11773393

    Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  11. US 11773143

    Conformational epitopes in respiratory syncytial virus G protein central conserved region

    The Regents of the University of California · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  12. US 11771666

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  13. US 11771680

    Pyrrole compounds

    Aligos Therapeutics, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  14. US 11771671

    Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, attention deficit hyperactivity disorder and addiction

    OVID THERAPEUTICS INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  15. US 11771664

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  16. US 11771687

    Substituted diazaspiroalkanes as androgen receptor modulators

    The Regents of the University of California · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  17. US 11771737

    Treating or preventing adverse liver conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  18. US 11771748

    Methods for treating tumor-induced osteomalacia

    Ultragenyx Pharmaceutical Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  19. US 11771751

    Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, streptococcus vaccines, and methods for making and using them

    The Regents of the University of California · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  20. US 11773119

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  21. US 11773051

    S-enantiomers of beta-hydroxybutyrate and butanediol and methods for using same

    The Regents of the University of California · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  22. WO 2023183767

    MÉTHODES ET COMPOSITIONS POUR AUGMENTER LA SENSIBILITÉ À L'INSULINE

    ABBOTT LAB [US] · Granted Sep 28, 2023 · Expires Sep 23, 2043

    granted
  23. US 2023302008

    METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Sep 28, 2023 · Expires Sep 23, 2043

    granted
  24. US 11769597

    Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.